Lavo AI

Lavo AI is a specialized web platform that uses artificial intelligence to predict the crystal structures of small molecule drugs. Its primary function is to help pharmaceutical researchers identify potential polymorphs—different solid forms a drug can take—which is a critical step in drug development. The tool analyzes molecular data to forecast how a compound will crystallize, providing insights that are traditionally gained through slow and expensive lab experiments. This allows teams to foresee formulation challenges much earlier in the process. The core of the platform is Crystal Console, which offers a suite of analysis tools. Users can import and visualize crystal structures, run virtual screens to find potential polymorphs, and compare their own experimental PXRD (Powder X-ray Diffraction) data against the AI's predictions. This integrated approach gives a comprehensive view of a drug's solid-state behavior. Lavo AI is built for professionals in the pharmaceutical industry who need to make critical decisions about drug candidates. It is most beneficial for research teams looking to de-risk their development pipeline by identifying stable, manufacturable crystal forms early on. The technology helps avoid late-stage surprises related to crystal form changes, which can cause significant delays and cost overruns, making the entire drug development process more efficient and predictable.